@article{larrey:hal-00866859,
TITLE = {Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-$\alpha$2a (40 KD) plus ribavirin.},
AUTHOR = {Larrey, Dominique and Carenco, Christophe and Guyader, Dominique and Boyer, Nathalie and Benhamou, Yves and Pageaux, Georges-Philippe and Rouzier, Regine and Marcellin, Patrick},
URL = {https://hal.science/hal-00866859},
JOURNAL = {Antiviral Therapy},
PUBLISHER = {International Medical Press},
VOLUME = {17},
NUMBER = {5},
PAGES = {927-32},
YEAR = {2012},
DOI = {10.3851/IMP2126},
KEYWORDS = {Nucleoside analog ; Cytokine ; Danoprevir ; Antineoplastic agent ; Antiviral ; Ribavirin ; Drug combination ; Interferon alpha 2a ; Pegylated form ; Treatment},
HAL_ID = {hal-00866859},
HAL_VERSION = {v1},
}